The Prevalence and the Effect of HCV NS5A Resistance-Associated Variants in Patients With Compensated Cirrhosis Treated With Ledipasvir/Sofosbuvir ± RBV

Press/Media: Press / Media

PeriodApr 30 2015

Media coverage

1

Media coverage

  • TitleThe Prevalence and the Effect of HCV NS5A Resistance-Associated Variants in Patients With Compensated Cirrhosis Treated With Ledipasvir/Sofosbuvir ± RBV
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date4/30/15
    PersonsEric J Lawitz